The association between interleukin-8 gene polymorphism and the risk of sepsis in older adults

白细胞介素-8基因多态性与老年人脓毒症风险之间的关联

阅读:1

Abstract

BACKGROUND: Previous studies on the relationship between interleukin-8 (IL-8) rs4073 polymorphism and sepsis susceptibility have covered contradictory results. Our purpose is to investigate whether this polymorphism confers a risk for sepsis using both experimental methods and meta-analysis. METHODS: In the current study, the authoritative databases including PubMed and Embase were carefully searched and reviewed. The search period spanned from the inception of each database until June 2024. Odds ratio (OR) and 95% confidence interval (CI) were adopted to compute the association strength. A total of 480 patients and 840 healthy individuals in older adults were selected. PCR-RFLP was applied to investigate the gene polymorphism including genotype frequency and allele frequency. RESULTS: In summary, no significant association was found by allele contrast (T vs. A: OR = 1.11, 95% CI = 0.75-1.62, P = 0.606), homozygote comparison (TT vs. AA: OR = 1.35, 95% CI = 0.57-3.20, P = 0.498), heterozygote comparison (AT vs. AA: OR = 1.38, 95% CI = 0.72-2.65, P = 0.668), recessive genetic model (TT vs. AA/TA: OR = 0.96, 95% CI = 0.64-1.43, P = 0.834), or dominant genetic model (TT/TA vs. AA: OR = 1.37, 95% CI = 0.68-2.79, P = 0.380). Analysis of the IL-8 gene polymorphism revealed three genotypes: AA, TA, and TT. We found that TT genotype and T allele were significantly associated with sepsis risk in older adults (all p < 0.05). CONCLUSION: The meta-analysis indicates no positive findings. However, the present experimental study has demonstrated that the IL-8 rs4073 polymorphism contributes increased risk to sepsis for older adults from Zhejiang Province, China. Future studies are urgently needed to confirm our conclusion.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。